Article Details
Retrieved on: 2020-12-01 17:36:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... just below the skin for high-volume delivery of <b>monoclonal antibodies</b> and other related drugs, company CEO Helen Torley said in an interview.
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here